Stay updated on CD133+ Stem Cell Implantation in CABG: Clinical Trial

Sign up to get notified when there's something new on the CD133+ Stem Cell Implantation in CABG: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD133+ Stem Cell Implantation in CABG: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents the assessment of safety, feasibility, and efficacy of intramyocardial delivery of selected autologous CD133+ bone marrow stem cells at the time of coronary artery bypass grafting in patients with chronic ischemic cardiomyopathy.
    Difference
    0.1%
    Check dated 2024-06-06T14:35:13.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.' This change provides a more detailed explanation of what eligibility criteria entail.
    Difference
    34%
    Check dated 2024-05-22T21:15:43.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:13:35.000Z thumbnail image

Stay in the know with updates to CD133+ Stem Cell Implantation in CABG: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD133+ Stem Cell Implantation in CABG: Clinical Trial page.